Oncology / Liquid Biopsy

Circulating nucleic acids have emerged as important biomarkers for cancer diagnostics and the detection of various clinical conditions. Utilizing liquid biopsy as an alternative to invasive and at times inaccessible tumor biopsy may enable access to critical information about disease composition and progression. Translational genomics research is utilizing both circulating cell-free DNA (cfDNA) and circulating tumor DNA (ctDNA) to monitor disease based on specific tumor profiles. To access this valuable information, it is critical to use next-generation sequencing (NGS) to detect variants in low levels of cfDNA from blood samples.

Swift Biosciences’ advanced technology offers an array of pre-designed and customizable Accel-Amplicon™ and Swift Amplicon High Sensitivity (HS) Panels optimized for multiple sequencing platforms to enable a fast, comprehensive approach to targeted liquid biopsy sequencing.

Oncology/Liquid Biopsy


Select a product and quantity:

For Variant Frequencies >1%

Low Frequency Somatic Mutations

NIPT/Oncology in cfDNA

For Heavily Damaged Samples

Shopping Cart


View Cart Checkout

Not sure of which kit is right for you?

Contact our Tech Support to assist.